These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10234527)

  • 1. Dry coating: an innovative enteric coating method using a cellulose derivative.
    Obara S; Maruyama N; Nishiyama Y; Kokubo H
    Eur J Pharm Biopharm; 1999 Jan; 47(1):51-9. PubMed ID: 10234527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
    Thoma K; Bechtold K
    Eur J Pharm Biopharm; 1999 Jan; 47(1):39-50. PubMed ID: 10234526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry coating in a rotary fluid bed.
    Kablitz CD; Harder K; Urbanetz NA
    Eur J Pharm Sci; 2006 Feb; 27(2-3):212-9. PubMed ID: 16290285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a stable aqueous enteric coating formulation with hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) and colloidal silicon dioxide as anti-tacking agent.
    Deshpande TM; Quadir A; Obara S; Ibrahim A; Hoag SW
    Int J Pharm; 2018 May; 542(1-2):108-116. PubMed ID: 29458205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 2000 May; 49(3):243-52. PubMed ID: 10799816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
    Williams RO; Liu J
    Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the process parameters of the dry coating process using a 2(5-1) factorial design.
    Kablitz CD; Urbanetz NA
    Pharm Dev Technol; 2013 Feb; 18(1):39-45. PubMed ID: 21851294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets. I. Drug release rates from coated pellets.
    Frohoff-Hülsmann MA; Schmitz A; Lippold BC
    Int J Pharm; 1999 Jan; 177(1):69-82. PubMed ID: 10205604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of formulation excipients on the thermal, mechanical, and electrokinetic properties of hydroxypropyl methylcellulose acetate succinate (HPMCAS).
    Deshpande TM; Quadir A; Obara S; Hoag SW
    Int J Pharm; 2018 May; 542(1-2):132-141. PubMed ID: 29458211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry coating of soft gelatin capsules with HPMCAS.
    Cerea M; Foppoli A; Maroni A; Palugan L; Zema L; Sangalli ME
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1196-200. PubMed ID: 18720149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
    Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
    AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles.
    Kim IH; Park JH; Cheong IW; Kim JH
    J Control Release; 2003 Apr; 89(2):225-33. PubMed ID: 12711446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility parameters of hypromellose acetate succinate and plasticization in dry coating procedures.
    Klar F; Urbanetz NA
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1621-35. PubMed ID: 26925982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.